Avanos Medical Inc (AVNS) Stock

DelistedNYSE: AVNSAvanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

24.99
Final close · Jul 24, 2026

AVNS is no longer traded. Avanos Medical was taken private by AIP in July 2026.

Prices on this page are historical; the last trade was July 24, 2026 at $24.99.

Avanos Medical stock price history

Split-adjusted closes, 2014–2026

AVNS final trading statistics

Final close
$24.99
Final trading day
Jul 24, 2026
Market cap at delisting
$1.17B
Shares outstanding
46.85M
Final 52-week range
$9.30 – $25.49
Avg. volume (final 3 mo.)
1,096,037
All-time high (split-adj.)
$72.65 · Sep 2018
All-time low (split-adj.)
$9.89 · Aug 2025
Return since IPO
-39.0%
Beta
1.57
Book value / share
$16.76
Price / book
1.49
Final 52 wk
9.3025.49

Avanos Medical earnings per share

Earnings per share

Avanos Medical revenue & net income

RevenueNet income

Avanos Medical annual financials

Avanos Medical Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$701.20M-$67.9M$0.94
FY2024$687.80M-$392.1M$1.32
FY2023$673.30M-$61.8M$1.13
FY2022$684.10M$50.5M$1.65
FY2021$744.60M$6.3M$1.15

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical stock FAQ

What happened to Avanos Medical stock?

Avanos Medical was taken private by AIP in July 2026. AVNS stock stopped trading on the NYSE, with a final close of $24.99 on July 24, 2026.

Is AVNS stock still trading?

No. AVNS was delisted from the NYSE in July 2026 and no longer trades on a U.S. exchange.

What was the last price of AVNS stock?

AVNS closed at $24.99 on its final trading day, July 24, 2026, for a market value of about $1.17B.

What were Avanos Medical's revenue and earnings in its last full fiscal year?

Avanos Medical reported revenue of $701.20M and net income of -$67.9M in fiscal 2025, its last full year as a public company.

When did Avanos Medical go public?

Avanos Medical Inc stock began trading on October 21, 2014.

Medical Devices stocks to research

All Healthcare stocks →